United Therapeutics Corp.
(NASDAQ : UTHR)

( )
UTHR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc 0.57%72.826.7%$204.64m
VRXValeant Pharmaceuticals International, Inc. 1.63%17.4714.1%$102.80m
BHCBausch Health Cos., Inc. 1.63%17.470.0%$81.00m
JAZZJazz Pharmaceuticals Plc 0.93%124.262.4%$77.40m
CTLTCatalent, Inc. -1.62%86.982.2%$69.19m
PRGOPerrigo Co. Plc 1.45%53.406.8%$49.06m
TNXPTonix Pharmaceuticals Holding Corp. -10.53%1.020.5%$48.96m
ARGXargenx SE -1.12%234.750.0%$44.00m
GWPHGW Pharmaceuticals Plc -1.89%106.436.2%$42.98m
ICPTIntercept Pharmaceuticals, Inc. -3.97%49.8016.8%$42.46m
PCRXPacira Biosciences, Inc. 0.91%61.2310.2%$40.54m
VRNAVerona Pharma Plc 14.90%8.250.0%$39.43m
AMRNAmarin Corp. Plc 1.48%6.861.5%$39.37m
ICLRICON plc -2.19%187.924.3%$38.82m
MYOKMyoKardia, Inc. -2.39%99.241.8%$37.29m

Company Profile

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.